Pfizer Inc.
PFE
Rank in Stocks
#121
Pfizer Inc. is a global biopharmaceutical leader engaged in the research,... Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Share Price
$29.55
Last synced: 2026-10-16
Market Cap
$168.40B
Change (1 day)
0.37%
Change (1 year)
20.54%
Country
US
Trade Pfizer Inc. (PFE)
Category
Healthcare
Operating Margin for Pfizer Inc. (PFE)
Operating Margin as of October 2026 TTM: 25.08%
According to Pfizer Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 25.08%. At the end of 2024 the company had an Operating Margin of 25.91%.
Operating Margin history for Pfizer Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 25.08% | 1.66% |
| 2025 | 24.67% | -4.79% |
| 2024 | 25.91% | 191.45% |
| 2023 | 8.89% | -76.25% |
| 2022 | 37.43% | 46.33% |
| 2021 | 25.58% | 17.29% |
| 2020 | 21.81% | 19.57% |
| 2019 | 18.24% | -36.00% |
| 2018 | 28.50% | 4.05% |
| 2017 | 27.39% | 1.37% |
| 2016 | 27.02% | -0.73% |
| 2015 | 27.22% | -3.75% |
| 2014 | 28.28% | -13.62% |
| 2013 | 32.74% | -0.79% |
| 2012 | 33.00% | 9.56% |
| 2011 | 30.12% | 13.92% |
| 2010 | 26.44% | -17.40% |
| 2009 | 32.01% | -7.00% |
| 2008 | 34.42% | 19.72% |
| 2007 | 28.75% | -7.85% |
| 2006 | 31.20% | 1.79% |
| 2005 | 30.65% | -5.81% |
| 2004 | 32.54% | 36.15% |
| 2003 | 23.90% | -36.99% |
| 2002 | 37.93% | 11.49% |
| 2001 | 34.02% | 16.03% |
| 2000 | 29.32% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 49.72% | -98.02% |
US
|
|
| 25.70% | -98.98% |
US
|
|
| 29.32% | -98.83% |
US
|
|
| 26.59% | -98.94% |
CH
|
|
| 16.65% | -99.34% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.